These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32814269)

  • 1. Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics.
    Nixon SA; Welz C; Woods DJ; Costa-Junior L; Zamanian M; Martin RJ
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():8-16. PubMed ID: 32814269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foreword: towards markers for anthelmintic resistance in helminths of importance in animal and human health.
    Prichard RK; von Samson-Himmelstjerna G; Blackhall WJ; Geary TG
    Parasitology; 2007; 134(Pt 8):1073-6. PubMed ID: 17608966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery.
    Herath HMPD; Taki AC; Rostami A; Jabbar A; Keiser J; Geary TG; Gasser RB
    Biotechnol Adv; 2022; 57():107937. PubMed ID: 35271946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing anthelmintic resistance--parasite fitness, drug use strategy and the potential for reversion towards susceptibility.
    Leathwick DM
    Vet Parasitol; 2013 Nov; 198(1-2):145-53. PubMed ID: 24074608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will technology provide solutions for drug resistance in veterinary helminths?
    von Samson-Himmelstjerna G; Blackhall W
    Vet Parasitol; 2005 Sep; 132(3-4):223-39. PubMed ID: 16118040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present-day anthelmintics and perspectives on future new targets.
    Taman A; Azab M
    Parasitol Res; 2014 Jul; 113(7):2425-33. PubMed ID: 24894082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities for the adoption of molecular diagnostics for anthelmintic resistance.
    Kotze AC; Gilleard JS; Doyle SR; Prichard RK
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():264-273. PubMed ID: 33307336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of anthelmintic resistance.
    Sangster N
    Parasitology; 1996; 113 Suppl():S201-16. PubMed ID: 9051936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Approaches to Investigate Anthelmintic Resistance.
    Doyle SR; Cotton JA
    Trends Parasitol; 2019 Apr; 35(4):289-301. PubMed ID: 30733094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research agenda for helminth diseases of humans: intervention for control and elimination.
    Prichard RK; Basáñez MG; Boatin BA; McCarthy JS; García HH; Yang GJ; Sripa B; Lustigman S
    PLoS Negl Trop Dis; 2012; 6(4):e1549. PubMed ID: 22545163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming drug resistance for macro parasites.
    Srivastava M; Misra-Bhattacharya S
    Future Microbiol; 2015; 10(11):1783-9. PubMed ID: 26517758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research.
    Geary TG; Thompson DP; Klein RD
    Int J Parasitol; 1999 Jan; 29(1):105-12; discussion 113-4. PubMed ID: 10048823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.
    Martin RJ; Robertson AP
    Adv Exp Med Biol; 2010; 692():138-54. PubMed ID: 21189677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host pharmacokinetics and drug accumulation of anthelmintics within target helminth parasites of ruminants.
    Lifschitz A; Lanusse C; Alvarez L
    N Z Vet J; 2017 Jul; 65(4):176-184. PubMed ID: 28415922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Xenobiotic-Metabolizing Enzymes in Anthelmintic Deactivation and Resistance in Helminths.
    Matoušková P; Vokřál I; Lamka J; Skálová L
    Trends Parasitol; 2016 Jun; 32(6):481-491. PubMed ID: 26968642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic drug discovery: into the future.
    Geary TG; Sakanari JA; Caffrey CR
    J Parasitol; 2015 Apr; 101(2):125-33. PubMed ID: 25584662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthelmintic resistance in human helminths: a review.
    Geerts S; Gryseels B
    Trop Med Int Health; 2001 Nov; 6(11):915-21. PubMed ID: 11703846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class?
    Leathwick DM; Hosking BC; Bisset SA; McKay CH
    N Z Vet J; 2009 Aug; 57(4):181-92. PubMed ID: 19649011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Products Are a Promising Source for Anthelmintic Drug Discovery.
    Jayawardene KLTD; Palombo EA; Boag PR
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelmintic metabolism in parasitic helminths: proteomic insights.
    Brophy PM; MacKintosh N; Morphew RM
    Parasitology; 2012 Aug; 139(9):1205-17. PubMed ID: 22776506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.